TGFB1 and Hepatic fibrosis: demonstrated that treatment with NK-Exo significantly inhibited TGF-β1-induced proliferation and activation of hepatic stellate cells, as well as liver fibrosis, thus providing a new means for the treatment of liver fibrosis (290).